Role of allogeneic stem cell transplantation in FLT3/ITD-positive AML.
Meshinchi
Soheil
S
Arceci
Robert J
RJ
Sanders
Jean E
JE
Smith
Franklin O
FO
Woods
William B
WB
Radich
Jerald P
JP
Alonzo
Todd A
TA
D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007951:Leukemia, Myeloid / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy*; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D051941:fms-Like Tyrosine Kinase 3 / Q000378:metabolism*
C497970:FLT3 protein, human; D051941:fms-Like Tyrosine Kinase 3